Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc > THe REaL INFeCTION

<< Previous

Bullboard Posts

Next >>

Comment by kindvalueon Apr 07, 2020 9:44pm

195 Views

Post# 30888872

RE:RE:THe REaL INFeCTION

my main point is forget covid
the other assets have value and the stock is very cheap
008 / occular - ideally the company pursues developing as occular is the best indication and Alexion really missed out by not securing - other pharmas would like to partner on this but best they do some development work then find a partner
Amp B data soon and the stock has ripped on positive data before so watch out - could be big
Alexion should just buy ICO - perhaps they were in the market today as that was good volume
but why should they pay $6M on BERT milestone and then pay royalties and still not own 008
JUST BUY ICO

<< Previous

Bullboard Posts

Next >>

Nintendo stock jumps despite Q2 financials, new console news